BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 35545568)

  • 21. Overcoming a "probable" diagnosis in antimitochondrial antibody negative primary biliary cirrhosis: study of 100 sera and review of the literature.
    Bizzaro N; Covini G; Rosina F; Muratori P; Tonutti E; Villalta D; Pesente F; Alessio MG; Tampoia M; Antico A; Platzgummer S; Porcelli B; Terzuoli L; Liguori M; Bassetti D; Brusca I; Almasio PL; Tarantino G; Bonaguri C; Agostinis P; Bredi E; Tozzoli R; Invernizzi P; Selmi C
    Clin Rev Allergy Immunol; 2012 Jun; 42(3):288-97. PubMed ID: 21188646
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implication of increased serum stromal cell-derived factor-1 for primary biliary cholangitis.
    Yang Z; Liang Y; Lin F; Zhang Z; Luo W; Zhang Y; Zhong R
    Int Immunopharmacol; 2018 Mar; 56():285-290. PubMed ID: 29414663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effects of Li-Dan-He-Ji on regulating oxidative stress and antagonising infantile cholestatic hepatic fibrosis].
    Yi W; Yan S; Tang J; Ma X; Su M; Li H
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Jul; 35(7):741-745. PubMed ID: 37545453
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The antinuclear autoantibodies Sp100 and gp210 persist after orthotopic liver transplantation in patients with primary biliary cirrhosis.
    Luettig B; Boeker KH; Schoessler W; Will H; Loges S; Schmidt E; Worman HJ; Gershwin ME; Manns MP
    J Hepatol; 1998 May; 28(5):824-8. PubMed ID: 9625318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The value of antinuclear antibodies in primary biliary cirrhosis.
    Gao L; Tian X; Liu B; Zhang F
    Clin Exp Med; 2008 Mar; 8(1):9-15. PubMed ID: 18385935
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peri-nuclear antibodies correlate with survival in Greek primary biliary cirrhosis patients.
    Sfakianaki O; Koulentaki M; Tzardi M; Tsangaridou E; Theodoropoulos PA; Castanas E; Kouroumalis EA
    World J Gastroenterol; 2010 Oct; 16(39):4938-43. PubMed ID: 20954280
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of classical and novel autoantibodies for the diagnosis of Primary Biliary Cholangitis-Autoimmune Hepatitis Overlap Syndrome (PBC-AIH OS).
    Nguyen HH; Shaheen AA; Baeza N; Lytvyak E; Urbanski SJ; Mason AL; Norman GL; Fritzler MJ; Swain MG
    PLoS One; 2018; 13(3):e0193960. PubMed ID: 29554146
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RANK/RANKL Acts as a Protective Factor by Targeting Cholangiocytes in Primary Biliary Cholangitis.
    Hao YL; Bian ZL; Ju LL; Liu Y; Qin G
    Dig Dis Sci; 2020 Feb; 65(2):470-479. PubMed ID: 31377883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical manifestation and autoantibody profile in 123 patients with primary biliary cirrhosis].
    Liu HH; Fu JL; Xu J; Luo SQ; Liu ZW; Wang FS
    Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Apr; 45(2):233-7. PubMed ID: 23591343
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Meta-analysis of anti-GP210 antibody and anti-SP100 antibody detection for diagnosis of primary biliary cirrhosis].
    Deng HM; Hu SL; Chen WX; Huang Y
    Zhonghua Gan Zang Bing Za Zhi; 2016 Jan; 24(1):62-8. PubMed ID: 26983392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Using two-step cluster analysis to classify inpatients with primary biliary cholangitis based on autoantibodies: A real-world retrospective study of 537 patients in China.
    Zhao DT; Yan HP; Liao HY; Liu YM; Han Y; Zhang HP; Zhang WM; Huang CY; Liu XH; Lou JL; Zhao Y
    Front Immunol; 2022; 13():1098076. PubMed ID: 36685575
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of anti-kelch-like 12 and anti-hexokinase 1 antibodies in primary biliary cholangitis patients in China.
    Liu ZY; Xu L; Liu B
    Rev Esp Enferm Dig; 2021 Aug; 113(8):585-590. PubMed ID: 33307711
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased sensitivity of gp210 autoantibody detection using a newly designed gp210 antigen.
    Xu J; Zhang H; Wang C; Jiang P; Han C; Dai Y; Qiu F; Gong Y; Jiang Y; Xu P; Zhang M; Zhang L; Shi X; Chen S; Tian Y; Seldin MF; Gershwin ME; Liu X; Li L
    J Immunol Methods; 2022 Feb; 501():113211. PubMed ID: 34971632
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinicopathological analysis of anti-mitochondrial antibody negative primary biliary cholangitis-autoimmune hepatitis overlap syndrome].
    Tan XY; Miao Q; Chen XY
    Zhonghua Gan Zang Bing Za Zhi; 2019 May; 27(5):376-380. PubMed ID: 31177663
    [No Abstract]   [Full Text] [Related]  

  • 35. Autoantibodies by line immunoassay in patients with primary biliary cirrhosis.
    Saito H; Takahashi A; Abe K; Okai K; Katsushima F; Monoe K; Kanno Y; Ohira H
    Fukushima J Med Sci; 2012; 58(2):107-16. PubMed ID: 23237866
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fluctuations of antimitochondrial antibodies and anti-gp210 antibody in a patient with primary biliary cholangitis and Sjögren syndrome with subsequent autoimmune hemolytic anemia: A case report.
    Zhao DT; Liu YM; Han Y; Zhang HP; Zhao Y; Yan HP
    Medicine (Baltimore); 2020 Jan; 99(3):e18856. PubMed ID: 32011506
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Measurement of gp210 autoantibodies in sera of patients with primary biliary cirrhosis.
    Bauer A; Habior A
    J Clin Lab Anal; 2007; 21(4):227-31. PubMed ID: 17621358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibody titer to gp210-C terminal peptide as a clinical parameter for monitoring primary biliary cirrhosis.
    Nakamura M; Shimizu-Yoshida Y; Takii Y; Komori A; Yokoyama T; Ueki T; Daikoku M; Yano K; Matsumoto T; Migita K; Yatsuhashi H; Ito M; Masaki N; Adachi H; Watanabe Y; Nakamura Y; Saoshiro T; Sodeyama T; Koga M; Shimoda S; Ishibashi H
    J Hepatol; 2005 Mar; 42(3):386-92. PubMed ID: 15710222
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation between individual autoantibodies and clinical features in primary biliary cholangitis: results of a retrospective longitudinal study.
    Dias B; Aguiar A; Morais CI; Nery FG
    Eur J Gastroenterol Hepatol; 2023 Jun; 35(6):682-689. PubMed ID: 37116005
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Magnesium isoglycyrrhizinate prevention of chemotherapy-induced liver damage during initial treatment of patients with gastrointestinal tumors].
    Yan Y; Mo Y; Zhang D
    Zhonghua Gan Zang Bing Za Zhi; 2015 Mar; 23(3):204-8. PubMed ID: 25938834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.